gliptin and glp 1 Frontiers Can patients take GLP-1 and

SS-31 Dosing Protocol (2026) Complete Guide Beginner Protocol Designed for first-time SS-31 users assessing tolerance and initial response: Dose: 5 mg per injection Frequency: 3x per week (e.g., Monday, Wednesday, Friday) Duration: 4 to 8 weeks initial assessment phase Administration: subcutaneous injection, abdominal or thigh, 3060 minutes before intended most-active period or morning Assessment: track energy levels, physical recovery, and cognitive stamina as primary indicators Follow-up: physician evaluation at 4 to 6 weeks to assess response and adjust The beginner protocol prioritizes tolerance assessment and establishing a consistent injection habit before advancing to higher doses or frequencies

For such patients, new GLP-1 drugs appear as a "chance to change myself who couldn't lose weight even after trying," and they are a great hope

it's understanding that peptides are fragile three-dimensional molecules that unfold permanently when shaken, overheated, or exposed to incompatible solvents

Exercise improves insulin sensitivity, regulates hunger signals, and supports lean muscle retention